Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under Pelthos Therapeutics Inc. in our court records and SEC 8-K records (as of 2026-10-18).
- Leadership changes: the latest reported is John M. Gay, Chief Financial Officer (Form 8-K filed 2026-04-10). Check you are dealing with the people now in charge.
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names Ikarian Capital, LLC (filed 2026-05-15).
Who is behind it
Pelthos Therapeutics Inc.: incorporated in Nevada; business address in Durham, North Carolina; industry Biological Products, (No Diagnostic Substances) (Schedule 13G/A, 2026-05-15).
Officers and directors, each with the role and the filing that names them:
- Scott Plesha: Executive Officer, Director (Form D, 2025-11-19)
- Francis Knuettel II: Executive Officer (Form D, 2025-11-19)
- Sai Rangarao: Executive Officer (Form D, 2025-11-19)
- Richard Baxter: Director (Form D, 2025-11-19)
- Peter Greenleaf: Director (Form D, 2025-11-19)
- Ezra Friedberg: Director (Form D, 2025-11-19)
- Todd Davis: Director (Form D, 2025-11-19)
- Richard Malamut: Director (Form D, 2025-11-19)
- Matthew Pauls: Director (Form D, 2025-11-19)
| Report | Holder | Share |
|---|---|---|
| Schedule 13G/A, 2026-05-15 | Ikarian Capital, LLC | 7.7% |
| Schedule 13G/A, 2026-05-07 | 3i, LP | 9.9% |
| Schedule 13G/A, 2026-02-17 | Ikarian Capital, LLC | 8.4% |
| Schedule 13G/A, 2026-02-05 | 3i, LP | 9.9% |
| Schedule 13G/A, 2025-11-14 | Ikarian Capital, LLC | 6.1% |
| Schedule 13G, 2025-11-14 | Murchinson LTD. | 9.1% |
| Schedule 13D/A, 2025-11-10 | Ligand Pharmaceuticals Incorporated | 49.9% |
| Schedule 13G/A, 2025-08-13 | Ame Equities LLC | 0% |
| Filed | Person | Role | Change | Effective |
|---|---|---|---|---|
| Form 8-K, 2026-04-10 | John M. Gay | Chief Financial Officer | appointed | 2026-04-10 |
| Form 8-K, 2026-04-10 | John M. Gay | appointed | 2026-04-10 |
Money raised
| Filed | Sold | Offered |
|---|---|---|
| Form D, 2025-11-19 | $18M | $18M |
| Form D, 2025-07-10 | $50.10M | $50.10M |
| Form D, 2024-08-06 | $750K | $750K |
| Form D, 2024-08-06 | $0 | $30M |
Latest IPO step: Pelthos Therapeutics Inc. filed to go public (S-1, 2024-07-29).
IPO filings: S-1, 2024-07-29; ticker CHRO on NYSE American.
Related pages
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
Permanent URL:
https://mentionfox.com/who-owns/pelthos-therapeuticsLast updated 2026-10-18
Primary record: Schedule 13G/A, 2026-05-15 · Form D, 2025-11-19 · Form 8-K, 2026-04-10 · S-1, 2024-07-29
Who owns Pelthos Therapeutics Inc.? Owners, funding and legal record. MentionFox, 2026-10-18. https://mentionfox.com/who-owns/pelthos-therapeutics